Indian Pharma Majors, Including Dr Reddy's & Glenmark, Deny Allegations of Price Fixing in US
The homegrown drugmakers are among the 21 generic pharmaceutical firms and 15 other individual defendants against whom the Attorneys General of 49 US states, the Commonwealth of Puerto Rico and the District of Columbia had filed a complaint with respect to 116 generic drugs.